A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.
PHASE1
This study is to assesss the safety and immunogenicity of vaccine based on ...
Status
Completed
Location
University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine
Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity
PHASE1
Boost vaccinations sometimes have no effect because the body has got used t...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford
A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG
PHASE1
This is a phase I study to examine the safety and immunogenicity of MVA85A ...
Status
Completed
Location
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital